Epigral Limited
2,739words
4turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs.
2
32%
29%
1.3x
₹ 250
25%
₹ 10
₹ 2.5
18.34 MW
18%
2%
40%
Guidance — 6 items
Employees
opening
“900+ 32% 29% 5 Year Revenue CAGR (FY22) 5 Year EBITDA CAGR (FY22) 1.3x 29% Debt to Equity (FY22) ROCE (FY22) Capacity: Chlor-Alkali# – 421 KTPA Derivatives# – 190 KTPA Revenue from operations (₹ Cr) 5,000”
Manufacturing facility
opening
“The estimated capex for the project will be ₹ 250 Cr and it is expected to get commissioned by Q4FY24 Maiden Interim Dividend Strategic Update MFL board has declared its 1st maiden interim dividend of 25% on face value of ₹ 10 (₹ 2.5 per equity share) o Expansion projects of Chlorotoluene & its value chain and R&D Centre is moving as per schedule o MFL acquired 2,89,844.41 sq.”
Manufacturing facility
opening
“The new products that we commissioned in 9MFY23 have marginally started contributing to P&L and we expect that contribution to increase from Q4FY23 onwards.”
Manufacturing facility
opening
“We are ready with the basic infrastructure required for CPVC resin expansion; hence we will be able to execute this project faster and at a lower capex compared to the 1st phase.”
Manufacturing facility
opening
“This expansion will further strengthen our integrated complex as Chlorine will be consumed as a key raw material in CPVC resin.”
Manufacturing facility
opening
“This new capacity will reach optimum capacity of utilization by end of Q4FY23 11 | MEGHMANI FINECHEM LIMITED Operational Overview – Realisations Q3FY23 - Change in ECU and Sales Realization % YoY Caustic Soda ECU Realization 40% 2% 9% 49,336 51,330 45,852 48,041 46,614 Caustic Soda - ECU Caustic Potash - ECU Chloromethanes Hydrogen Peroxide -33% Q3FY22 Q4FY22 Q1FY23 Q2FY23 Q3FY23 o On a YoY basis ECU realization for Caustic Soda was marginally up (2%) and on QoQ it dropped marginally by 3%.”
Advertisement
Risks & concerns — 1 flagged
Even in this volatile market, we have seen volume growth in all our products and have grown on absolute basis.
— Manufacturing facility
Speaking time
1
1
1
1
Advertisement
Opening remarks
Employees
900+ 32% 29% 5 Year Revenue CAGR (FY22) 5 Year EBITDA CAGR (FY22) 1.3x 29% Debt to Equity (FY22) ROCE (FY22) Capacity: Chlor-Alkali# – 421 KTPA Derivatives# – 190 KTPA Revenue from operations (₹ Cr) 5,000
Manufacturing facility
Fully integrated and automated complex FY18 FY19 FY18 FY21 FY22 FY27E # Chlor-Alkali : Caustic Soda - 400 KTPA and Caustic Potash - 21 KTPA Derivatives : CPVC Resin – 30 KTPA, Epichlorohydrin – 50 KTPA, Chloromethane - 50 KTPA and Hydrogen Peroxide - 60 KTPA 3 | MEGHMANI FINECHEM LIMITED Key Highlights – Strategic Update Expansion MFL is expanding its CPVC Resin capacity to 75,000 TPA by adding further 45,000 TPA. The estimated capex for the project will be ₹ 250 Cr and it is expected to get commissioned by Q4FY24 Maiden Interim Dividend Strategic Update MFL board has declared its 1st maiden interim dividend of 25% on face value of ₹ 10 (₹ 2.5 per equity share) o Expansion projects of Chlorotoluene & its value chain and R&D Centre is moving as per schedule o MFL acquired 2,89,844.41 sq. m. land in Dahej (close to current complex) for future growth plans o MFL entered in JV to set up 18.34 MW Hybrid Power Plant to meet energy requirement at the plant o In 9MFY23, MFL commissioned Epichl
Advertisement